First Trust Advisors’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
DM
First Trust Advisors's ORGO Position: Q2 2022 in Review
First Trust Advisors sold out of Organogenesis Holdings (ORGO) in Q2 2022, closing a stake of 109,388 shares — an estimated $834K sold.
First Trust Advisors first reported a position in ORGO in Q2 2021 and held it in 4 quarters. The position peaked at $5.42M in Q2 2021. 146 funds tracked by Wall St. Rank hold ORGO as of Q2 2022.
- First Trust Advisors reported no remaining Organogenesis Holdings position as of Q2 2022 after selling out during the quarter.
- First Trust Advisors sold 109,388 Organogenesis Holdings shares in Q2 2022, an estimated $834K.
- First Trust Advisors first reported a position in Organogenesis Holdings in Q2 2021 and held it in 4 quarters.
- First Trust Advisors's Organogenesis Holdings position peaked at $5.42M in Q2 2021.
- 146 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2022.
Based on First Trust Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.